Vivos (RDGL) Share-based Compensation Growth (3y) (2013 - 2025)
Vivos (RDGL) Share-based Compensation Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.62 Mn | 26.06 Mn | -3,105.00 | 104.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104.57% |
| Sep 30, 2025 | 63.04% |
| Jun 30, 2025 | 0.77% |
| Mar 31, 2025 | 150.01% |
| Dec 31, 2024 | 182.37% |
| Mar 31, 2018 | -74.93% |
| Dec 31, 2017 | -73.46% |
| Sep 30, 2017 | 65.06% |
| Mar 31, 2017 | 37.34% |
| Sep 30, 2016 | 61.59% |
| Jun 30, 2016 | 97.72% |
| Mar 31, 2015 | -57.03% |
| Dec 31, 2014 | 66.37% |
| Mar 31, 2014 | -15.40% |
| Dec 31, 2013 | -12.52% |
| Sep 30, 2013 | -75.18% |